Other abnormal cytological findings on specimens from cervix uteri
ICD-10 R87.618 is a billable code used to indicate a diagnosis of other abnormal cytological findings on specimens from cervix uteri.
R87.618 is used to classify abnormal cytological findings from cervical specimens that do not fit into more specific categories. These findings may include atypical squamous cells of undetermined significance (ASC-US), atypical glandular cells, or other abnormal results that require further investigation. The abnormal findings can arise from various conditions, including infections, inflammation, or precancerous changes. It is crucial for healthcare providers to follow up on these findings with appropriate diagnostic procedures, such as colposcopy or biopsy, to determine the underlying cause and necessary treatment. Accurate coding of these findings is essential for proper patient management and tracking of cervical health.
Documentation must include detailed descriptions of cytological findings, follow-up plans, and any related symptoms.
Patients presenting with abnormal Pap smear results requiring further evaluation.
Ensure that all findings are clearly linked to the patient's history and any relevant risk factors.
Acute care documentation should include immediate findings and any urgent follow-up actions taken.
Patients presenting with acute symptoms related to cervical issues, such as bleeding or pain.
Consider the urgency of follow-up procedures and ensure documentation reflects the need for immediate care.
Used when performing a Pap smear to screen for cervical cancer.
Document the type of specimen collected and any relevant patient history.
Ensure that the procedure is linked to the diagnosis of abnormal findings.
Document the specific cytological findings, any follow-up actions taken, and the patient's clinical history to support the diagnosis.
